LANDINI, IDA
 Distribuzione geografica
Continente #
NA - Nord America 3.091
EU - Europa 2.439
AS - Asia 449
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 5.982
Nazione #
US - Stati Uniti d'America 3.083
PL - Polonia 1.360
IE - Irlanda 294
IT - Italia 276
SE - Svezia 232
HK - Hong Kong 192
CN - Cina 109
DE - Germania 76
JO - Giordania 63
FI - Finlandia 44
GB - Regno Unito 41
IN - India 24
CH - Svizzera 22
TR - Turchia 22
RU - Federazione Russa 19
UA - Ucraina 18
VN - Vietnam 18
AT - Austria 16
SG - Singapore 16
BE - Belgio 14
ES - Italia 11
CA - Canada 8
FR - Francia 7
DK - Danimarca 3
NL - Olanda 3
KR - Corea 2
CO - Colombia 1
CZ - Repubblica Ceca 1
ID - Indonesia 1
IR - Iran 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
SC - Seychelles 1
Totale 5.982
Città #
Warsaw 1.356
Fairfield 445
Chandler 328
Dublin 292
Ashburn 279
Seattle 224
Woodbridge 219
Cambridge 202
Houston 199
Wilmington 162
Ann Arbor 141
Hong Kong 132
Florence 95
Altamura 85
Lawrence 78
Princeton 69
Beijing 60
Buffalo 51
Boston 43
Bremen 42
Boardman 39
Shanghai 34
Jacksonville 32
Medford 30
Falls Church 27
New York 26
Kent 25
Bern 22
San Diego 19
Moscow 17
Vienna 16
Brussels 14
Chennai 13
Phoenix 12
Barcelona 11
Hillsboro 11
Izmir 11
Norwalk 11
Dong Ket 10
Council Bluffs 9
Pune 9
Singapore 9
Dearborn 8
London 8
Toronto 7
Laurel 5
Redwood City 5
Andover 4
Guangzhou 4
Romainville 4
Tappahannock 4
Washington 4
West Jordan 4
Kunming 3
Latina 3
Los Angeles 3
Prato 3
Redmond 3
Sesto Fiorentino 3
Sinalunga 3
Turin 3
Auburn Hills 2
Città Di Castello 2
Copenhagen 2
Fiesole 2
Frankfurt Am Main 2
Guagnano 2
Helsinki 2
Livorno 2
Naples 2
Padova 2
Perugia 2
Philadelphia 2
Poggibonsi 2
Radom 2
Radomsko 2
San Mateo 2
Torchiarolo 2
Trumbull 2
Aprilia 1
Arezzo 1
Atlanta 1
Auckland 1
Ayer 1
Baotou 1
Bitola 1
Bogotá 1
Bologna 1
Central District 1
Chiari 1
Esslingen am Neckar 1
Hangzhou 1
Hefei 1
Hounslow 1
Islington 1
Kilburn 1
Lappeenranta 1
Lisbon 1
Lucca 1
Lyngby 1
Totale 5.047
Nome #
Proteomic Analysis of Ovarian Cancer Cell Responses to Cytotoxic Gold Compounds 249
In vitro assessment of antibody-conjugated gold nanorods for systemic injections 243
Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies. 240
Effect of the SOD mimetic MnL4 on in vitro and in vivo oxaliplatin toxicity: Possible aid in chemotherapy induced neuropathy 237
Emerging drugs in refractory colorectal cancer 227
Proteomic analysis of the cytotoxic effects induced by the organogold(III) complex Aubipyc in cisplatin-resistant A2780 ovarian cancer cells: further evidence for the glycolytic pathway implication 223
The Inhibitory Effects of HYDAMTIQ, a Novel PARP Inhibitor, on Growth in Human Tumor Cell Lines With Defective DNA Damage Response Pathways. 219
Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study 219
Proteomic analysis of A2780/S ovarian cancer cell response to the cytotoxic organogold(III) compound Aubipy(c.) 210
Druggable Targets in Pancreatic Adenocarcinoma 195
MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin 170
Selection and characterization of a human ovarian cancer cell line resistant to auranofin 161
Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer 130
Exploring the biochemical mechanisms of cytotoxic gold compounds: a proteomic study. 109
Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies 109
Cellular pharmacology of gemcitabine. 107
Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: Solution behavior, reactions with model proteins, antiproliferative properties 104
Chemistry and Biology of Two Novel Gold(I) Carbene Complexes as Prospective Anticancer Agents 104
A transcriptomic profile predicts clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 102
Cytotoxic properties of a new organometallic platinum(II) complex and its gold(I) heterobimetallic derivatives. 101
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 99
Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression 90
Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand. 88
Fluoropyrimidine-related toxicity in gastrointestinal cancer patients. Assessment of risk factors. 85
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I. 85
Pharmacological strategies for overcoming multidrug resistance. 84
Identification Of Pharmacogenomic Markers Of Clinical Efficacy In A Dose-Dense Therapy Regimen (R-Chop14) In Diffuse Large B Cell Lymphoma 83
Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer 81
Role of Genetic Polymorphisms on Response to R-CHOP regimen in Diffuse Large B-cell Lymphoma Patients: an Interim Analysis of a Multicenter Prospective Pharmacogenetic Study 78
The molecular mechanisms of antimetastatic ruthenium compounds explored through DIGE proteomics 77
Structure, solution chemistry, antiproliferative actions and protein binding properties of non-conventional platinum(II) compounds with sulfur and phosphorus donors. 76
Synthesis, Structural Characterization, Solution Behavior, and in Vitro Antiproliferative Properties of a Series of Gold Complexes with 2-(2'-Pyridyl)benzimidazole as Ligand: Comparisons of Gold(III) versus Gold(I) and Mononuclear versus Binuclear Derivatives 75
Size dependent biological profiles of PEGylated gold nanorods 71
Erratum: The inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on growth in human tumor cell lines with defective DNA damage response pathways (Oncology Research 25:9 (1441-1451) DOI: 10.3727/096504017X14926854178616) 68
In vitro study on the safety of near infrared laser therapy in its potential application as postmastectomy lymphedema treatment 65
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 64
Role of ATP-binding cassette transporters in cancer initiation and progression 64
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer 63
Vinorelbine in non-small cell lung cancer: Real-World data from a single institution experience 60
Pharmacological modulation of protein kinase C for overcoming drug resistance in colorectal cancer. Preliminary results of in vitro studies. 59
Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers 58
Pharmacogenomic Markers of Clinical Efficacy in a Dose-Dense Therapy Regimen (R-CHOP14) in Diffuse Large B Cell Lymphoma 57
Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 56
THE IMPACT OF GENETIC POLYMORPHISMS ON R-CHOP EFFICACY IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: AN INTERIM ANALYSIS OF A MULTICENTER PROSPECTIVE PHARMACOGENETIC STUDY 55
PNN and KCNQ1OT1 can predict the efficacy of adjuvant fluoropyrimidine-based chemotherapy in colorectal cancer patients 55
Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy 52
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphysms in primary colorectal cancer patients. 48
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients 44
Cyclodextrin Inclusion Complexes of Auranofin and Its Iodido Analog: A Chemical and Biological Study 41
Structure-activity relationships in a series of auranofin analogues showing remarkable antiproliferative properties 39
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles 38
Pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B cell lymphoma: preliminary results 35
Thymidylate Synthase (TS) mRNA expression and TS gene promoter polymorphism in primary colorectal cancer (CRC) patients (PTS) receiving post-operative fluorouracil (5-FU)-based chemotherapy (CT) 34
Preliminary characterization of methotrexate (MTX) resistance mechanisms in human colon carcinoma cells DLD-1 32
Artificial Intelligence Predictive Models of Response to Cytotoxic Chemotherapy Alone or Combined to Targeted Therapy for Metastatic Colorectal Cancer Patients: A Systematic Review and Meta-Analysis 31
Sequence-dependent interactions between oxaliplatin (OHP) and 5-fluorouracil (5-FU) in human colon carcinoma cell lines 31
Molecular characterization of established human colorectal carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil (5-FU) by different selective schedules 30
The clinical role of PIK3CA mutations in colorectal cancer 29
Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma 29
Comparative genomic hybridization study of genetic changes associated with 5-fluorouracil resistance in HCT-8 colon cancer cell lines: correlations with the expression profiles 28
Sequence-dependent interactions between oxaliplatin and 5-fluorouracil in human colon carcinoma cell lines 28
Pharmacogenetics in diffuse large B-cell lymphoma treated with R-CHOP: Still an unmet challenge 27
Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs 26
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer 26
Mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1 26
Preliminary characterization of methotrexate (MTX) resistance mechanisms in human colon carcinoma cells DLD-1 24
Sequence-dependent interactions between oxaliplatin and 5-fluorouracil in human colon carcinoma cell lines 23
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles 22
Multiple mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1. 21
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 20
Multiple mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1 19
Mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1 13
Therapeutic drug monitoring for the cancer patient: challenges and opportunities 13
P118 A preliminary study for evaluation of cannabis - chemotherapy interactions on human colon cancer cells 9
In vitro cell growth inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on human tumor cell lines with defective DNA damage response pathways 8
Validation of single nucleotide polymorphisms potentially related to R-CHOP resistance in diffuse large B-cell lymphoma patients 5
Targeting z-Crystallin by aspirin restores the sensitivity to cisplatin in resistant A2780 ovarian cancer cells 4
Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs 4
null 2
Totale 6.116
Categoria #
all - tutte 17.752
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.752


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019141 0 0 0 0 0 0 0 0 0 0 0 141
2019/20201.350 107 119 47 99 158 145 148 161 131 100 117 18
2020/2021837 75 74 23 86 70 95 58 57 77 131 49 42
2021/2022511 13 40 39 17 22 28 36 48 30 17 91 130
2022/20231.480 111 265 68 141 114 262 174 84 174 7 31 49
2023/2024611 21 55 79 16 32 67 82 157 15 21 43 23
Totale 6.116